The deal introduces faster FTB mapping and quantitative susceptibility analysis to complement existing perfusion and contrast-enhancement solutions.Â
The cloud-based solution integrates maternal and fetal vital signs—such as uterine activity, blood pressure, and fetal heart rate—into a unified, chronological view to support efficient decision-making.
The move offers hospitals a new procurement and deployment channel for SaaS-based imaging software designed to improve workflow and data access.
The deal introduces faster FTB mapping and quantitative susceptibility analysis to complement existing perfusion and contrast-enhancement solutions.Â
The recently cleared system is designed with a new imaging architecture and AI-driven tools to enhance workflow efficiency and diagnostic speed.
Read More
The company has now accumulated over 100 authorizations for artificial intelligence in its medical technology portfolio.
Read More
The floor-mounted digital X-ray system automates in-room workflows and repetitive tasks to help improve throughput and reduce the technologist learning curve.
Read More
From artificial intelligence-assisted troubleshooting to predictive platforms, vendors and end-users share what’s working—and what it takes to get there.
Read More
With disasters on the rise, HTM teams are relying on modern tools and coordinated planning to support smarter emergency response.
Read More
The Carestation anesthesia systems are being recalled due to a risk of ineffective ventilation in volume control mode, which could lead to serious injury or death.
Read More
New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.
